Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Safety monitoring for 'flu antivirals

The Medicines and Healthcare products Regulatory Agency has announced the launch of a online reporting mechanism for monitoring the safety of the swine flu antiviral medicines.

It is expected that usage of oseltamivir (Tamiflu®) and zanamavir (Relenza®) will increase during the swine flu pandemic. The Swine 'Flu ADR Portal can be used by healthcare professionals and the public to reported suspected adverse drug reactions (ADR) to either of these drugs.

Action: Clinicians should be aware of this portal and recommend it to patients with suspected ADRs. Clinicians should report adverse events for patients without internet access.

Share 'Safety monitoring for 'flu antivirals' on Email Share 'Safety monitoring for 'flu antivirals' on Delicious Share 'Safety monitoring for 'flu antivirals' on Digg Share 'Safety monitoring for 'flu antivirals' on Facebook Share 'Safety monitoring for 'flu antivirals' on Google+ Share 'Safety monitoring for 'flu antivirals' on reddit Share 'Safety monitoring for 'flu antivirals' on StumbleUpon Share 'Safety monitoring for 'flu antivirals' on Twitter

atomic-wealth

No Comments to “Safety monitoring for 'flu antivirals”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,309 spam comments.

atomic-wealth
fond-illness
summer